Matthew Gline - CEO, Director at Roivant Sciences Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
ROIV on Nasdaq
All Insider Reports
All Insider Reports

Matthew Gline - trading volume in the past year for Roivant Sciences Ltd.

Holdings reported by Matthew Gline for Roivant Sciences Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 17,287,081 $374,783,916 $21.68 15 Dec 2025 Direct
Stock Option (Right to Buy) 0 15 Dec 2025 Direct Common Stock

Transactions reported by Matthew Gline for Roivant Sciences Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.